医学
疱疹后神经痛
加巴喷丁
耐受性
普瑞巴林
观察研究
重症监护医学
慢性疼痛
随机对照试验
神经病理性疼痛
物理疗法
替代医学
精神科
麻醉
不利影响
药理学
外科
内科学
病理
作者
Tina Khadem,Vanessa Stevens
标识
DOI:10.3109/15360288.2013.816408
摘要
Postherpetic neuralgia (PHN) is a chronic and painful condition that may result in significant disturbances to normal activities and decreases in the quality of life for those affected. Despite the availability of several first- and second-line treatment options, many patients may experience refractory pain. The objectives of this review were to summarize evidence for Food and Drug Administration (FDA)-approved and off-label therapies for the treatment of PHN and to present gaps in the current literature for future research focus. Several agents, including pregabalin, gabapentin, and opioids, have been shown to significantly improve pain when compared with placebo. However, evidence regarding the comparative effectiveness of these treatment alternatives is lacking. In order to choose the optimal treatment, providers should consider issues related to efficacy, safety, and tolerability in conjunction with patient goals, preferences, and adherence issues. Evidence from randomized or observational studies that directly compare agents with each other should help to inform treatment choices.
科研通智能强力驱动
Strongly Powered by AbleSci AI